FDA Inspection
Manish Jain, M.D.Manish Jain, M.D. – FDA Inspection, Jan 24, 2022
Record Details
This FDA Inspection record concerns Manish Jain, M.D., with an inspection on January 24, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Manish Jain, M.D.
- Inspection Date
- January 24, 2022
- Product Type
- Drugs
View Company Profile
ID · 68228be9-b213-427b-81ee-a09fdfdedec4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1161119
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Manish Jain, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 8, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Manish Jain, M.D.
- FDA Inspection 1254828 - 2024-11-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.